LAMIVUDINE AND ZIDOVUDINE
Generic: LAMIVUDINE AND ZIDOVUDINE
Macleods Pharmaceuticals LimitedManufacturer
ORALRoute
LAMIVUDINEActive Substance
2018-08-29Original Approval
LAMIVUDINE AND ZIDOVUDINE is FDA application ANDA090679, sponsored by MACLEODS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FOETAL EXPOSURE DURING PREGNANCY
193 reports
2
MATERNAL EXPOSURE DURING PREGNANCY
133 reports
3
EXPOSURE DURING PREGNANCY
99 reports
4
PATHOGEN RESISTANCE
90 reports
5
VIROLOGIC FAILURE
80 reports
6
VIRAL MUTATION IDENTIFIED
77 reports
7
ABORTION SPONTANEOUS
61 reports
8
LIPODYSTROPHY ACQUIRED
49 reports
9
TREATMENT NONCOMPLIANCE
49 reports
10
PREMATURE BABY
48 reports